Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 3.200
+0.180 (5.96%)
Jun 19, 2025, 1:53 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 81.12 million as of June 18, 2025. Its market cap has decreased by -68.03% in one year.
Market Cap
81.12M
Enterprise Value
99.55M
Revenue
44.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.20
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 81.12M, a decrease of -87.86%. That is a compound annual growth rate of -38.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 81.12M | 74.72% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.43B |
| Nordhealth AS | 2.88B |
| Photocure ASA | 1.36B |
| Vistin Pharma ASA | 1.08B |
| Omda AS | 1.03B |
| Gentian Diagnostics ASA | 943.85M |
| ArcticZymes Technologies ASA | 855.45M |
| Thor Medical ASA | 830.04M |